Alison Lawton

Alison Lawton

Vermögen: - $ am 30.06.2026

63 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Alison Francis Lawton currently works at Dianthus Therapeutics, Inc., as Independent Chairman from 2023, AgBiome INC, as Director from 2021, SwanBio Therapeutics, Inc., as Director from 2021, Bluerock Therapeutics, Inc., as Director, and Cadena Bio, Inc., as President.
Ms. Lawton also formerly worked at Regulatory Affairs Professionals Society, as Chairman & President, Cubist Pharmaceuticals LLC, as Independent Director from 2012 to 2014, CoLucid Pharmaceuticals, Inc., as Director from 2016 to 2017, Spyre Therapeutics, Inc., as Independent Director, Follica, Inc., as Director, Massachusetts Medical Device Industry Council, as Director, Verastem, Inc., as Independent Director from 2012 to 2020, Kaleido Biosciences, Inc., as Director in 2020, Magenta Therapeutics, Inc., as Director from 2017 to 2018, Magenta Therapeutics, Inc., as Independent Director from 2020 to 2021, X4 Pharmaceuticals, Inc., as Independent Director from 2020 to 2025, Genzyme Corp., as Senior Vice President from 2011 to 2012, Aura Biosciences, Inc., as Chief Operating Officer from 2015 to 2017, Parke-Davis & Co. Ltd., as Principal, Genzyme Biosurgery Corp., as General Manager from 2012 to 2013, Sanofi, Inc., as General Manager-Biosurgery, OvaScience, Inc., as Chief Operating Officer from 2013 to 2014, Sanofi-Aventis, Inc., as Head-Genzyme Biosurgery, X4 Pharmaceuticals, Inc., as Chief Operating Officer from 2014 to 2017, BIOSURGERY S.R.L., as Senior Vice President & General Manager, and ProQR Therapeutics NV, as Independent Member-Supervisory Board from 2014 to 2026.
Ms. Lawton received her undergraduate degree from King's College London.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
18.03.2026 0 ( -.--% ) - $ 30.06.2026
21.05.2026 0 ( -.--% ) - $ 30.06.2026

Aktive Positionen von Alison Lawton

UnternehmenPositionBeginn
DIANTHUS THERAPEUTICS, INC. Vorsitzender 11.09.2023
Präsident -
Direktor/Vorstandsmitglied 04.05.2021
Direktor/Vorstandsmitglied 19.01.2021
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Alison Lawton

UnternehmenPositionEnde
PROQR THERAPEUTICS N.V. Direktor/Vorstandsmitglied 02.06.2026
X4 PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 09.06.2025
SPYRE THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.02.2024
KALEIDO BIOSCIENCES, INC. Vorstandsvorsitzender 16.06.2020
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Alison Lawton im Detail an

Ausbildung von Alison Lawton

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

91

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen25

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Retail Trade

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

  1. Börse
  2. Insiders
  3. Alison Lawton